Categories
CoVID-19 Human Health Investment Press Release

PRESS RELEASE: April 2022 – Mobility Health Partnership

Bolstered By Investment, Pictor Partners with Mobility Health to Offer PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster $6.1 Million investment for Pictor — led by Marko Bogoievski and K One W One Ltd. — to aid the market development of novel antibody testing and other in vitro diagnostics PRESS RELEASE – April […]

Categories
Clinical Trials CoVID-19 Human Health

PRESS RELEASE: PictArray SARS-CoV-2 USA Trials

Pictor Successfully Completes Validation Trial in U.S. for its SARS-Co-V-2 Antibody Test PRESS RELEASE – January 20, 2022 — New Zealand diagnostic biotech company Pictor Ltd. announced today that it has successfully completed validation trials at two separate sites in the United States, one of which was Florida-based Boca Biolistics, for its COVID-19 antibody test. The Pictor test […]

Categories
CoVID-19 Human Health

PRESS RELEASE: SEP 2021 – SCIENION Collaboration

Pictor and SCIENION partner to commercialise high-throughput SARS-CoV-2 antibody testing system to support ongoing fight against pandemic The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance PRESS RELEASE – September 29, 2021 — Auckland-based diagnostic biotech company Pictor has […]